Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Treatment of Buruli ulcer desease by excision and skin graft
Annales de Chirurgie Plastique Esthetique, Volume 49, No. 1, Year 2004
Notification
URL copied to clipboard!
Description
Introduction. - Buruli ulcer is the most common mycobacteria disease after leprosy and tuberculosis. The purpose of our study is to make our contribution to the surgical treatment of Buruli ulcer and to asses our results. Method. - One hundred eighteen patients presenting progressive Buruli ulcers were operated on. The surgical procedure included excisions for necrotic lesions and grafts for clean wounds. The results were estimated on the time of hospitalization and appearance of complications. Results. - Seventy-three patients (62%) were subjected to excision followed by thin skin grafts and 35 patients (30%) were subjected to grafts only. The number of excision times varies from 1 to 7 per patient and from 1 to 4 for the skin grafts. All our patients heal within a period of 120 days with extremes going from 14 to 265 days. We deplored 26 complications (22%): eight new focus, seven infectious complications, six recurrences, five stiffnesses and ankyloses. Conclusion. - The treatment of Buruli ulcer by excision and grafts is efficient but does not prevent recurrences and new focus from happening and for their prevention, it is necessary to discover pharmaceutical molecules that are efficient on Mycobacterium ulcerans. © 2003 Elsevier SAS. Tous droits réservés.
Authors & Co-Authors
Ouattara, Djibril N.
France, Villeneuve-saint-georges
Centre Hospitalier Intercommunal de Villeneuve-saint-georges
Méningaud, Jean Paul
France, Villeneuve-saint-georges
Centre Hospitalier Intercommunal de Villeneuve-saint-georges
France, Paris
Université Paris Cité
Kaba, Lanciné
Cote D'ivoire, Adzope
Institut Raoul-follereau de Cote-d'ivoire a Adzope
Sica, Asso
Cote D'ivoire, Adzope
Institut Raoul-follereau de Cote-d'ivoire a Adzope
Assé, Henry
Cote D'ivoire, Adzope
Institut Raoul-follereau de Cote-d'ivoire a Adzope
Statistics
Citations: 11
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1016/j.anplas.2003.04.001
Research Areas
Health System And Policy